<SEC-DOCUMENT>0000950127-22-000039-index.html : 20220812
<SEC-HEADER>0000950127-22-000039.hdr.sgml : 20220812
<ACCEPTANCE-DATETIME>20220812164610
ACCESSION NUMBER:		0000950127-22-000039
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220812
DATE AS OF CHANGE:		20220812
GROUP MEMBERS:		FORESITE CAPITAL FUND V, L.P.
GROUP MEMBERS:		FORESITE CAPITAL MANAGEMENT V, LLC
GROUP MEMBERS:		FORESITE CAPITAL OPPORTUNITY FUND V, L.P.
GROUP MEMBERS:		FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC
GROUP MEMBERS:		JAMES TANANBAUM

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gemini Therapeutics, Inc. /DE
		CENTRAL INDEX KEY:			0001816736
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				851613057
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91633
		FILM NUMBER:		221160826

	BUSINESS ADDRESS:	
		STREET 1:		300 ONE KENDALL SQUARE, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		(617) 401-4400

	MAIL ADDRESS:	
		STREET 1:		300 ONE KENDALL SQUARE, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FS Development Corp.
		DATE OF NAME CHANGE:	20200702

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FS Development Holdings, LLC
		CENTRAL INDEX KEY:			0001820810
		IRS NUMBER:				851613057

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		600 MONTGOMERY STREET
		STREET 2:		SUITE 4500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			94111
		BUSINESS PHONE:		415 877 4887

	MAIL ADDRESS:	
		STREET 1:		600 MONTGOMERY STREET
		STREET 2:		SUITE 4500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			94111
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>schedule13damend.htm
<DESCRIPTION>SCHEDULE 13D AMENDMENT
<TEXT>
Document 1 - file: schedule13damend.htm

</DOCUMENT>
</SEC-DOCUMENT>